[Faricimab (visual impairment due to macular oedema secondary to retinal vein occlusion) – Addendum to Project A24-85]
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen
Record ID 32018014330
German
Original Title:
Faricimab (Visusbeeinträchtigung infolge eines Makulaödems bei retinalem Venenverschluss) - Addendum zum Projekt A24-85
Details
Project Status:
Completed
URL for project:
https://www.iqwig.de/projekte/g25-03.html
Year Published:
2025
URL for published report:
https://www.iqwig.de/download/g25-03_faricimab_addendum-zum-projekt-a24-85_v1-1.pdf
English language abstract:
There is no English language summary available
Publication Type:
Full HTA
Country:
Germany
MeSH Terms
- Macular Edema
- Retinal Vein Occlusion
- Angiogenesis Inhibitors
- Intravitreal Injections
- Visual Acuity
Keywords
- Faricimab
- Retinal Vein Occlusion
- Macular Edema
- Benefit Assessment
Contact
Organisation Name:
Institute for Quality and Efficiency in Health Care (IQWiG)
Contact Address:
IQWiG, Siegburger Str. 237, 50679 Cologne, GERMANY, Tel: +49(0)221-35685, Fax: +49(0)221-356851
Contact Email:
berichte@iqwig.de
Copyright:
Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.